Last Updated On 2/25/2026 8:09:52 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
| Employment |
| Company: Bayer |
| Recipient: An Immediate Family Member |
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| Company: Bayer |
| Recipient: An Immediate Family Member |
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Merck Sharp & Dohme |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: Incyte |
| Recipient: You |
| Company: Seattle Genetics/Astellas |
| Recipient: You |
| Company: Bristol-Myers Squibb |
| Recipient: You |
| Company: Catalym |
| Recipient: You |
| Company: Gilead Sciences |
| Recipient: You |
| Company: Genenta Science |
| Recipient: You |
| Company: Johnson & Johnson/Janssen |
| Recipient: You |
| Company: Peerview |
| Recipient: You |
| Company: PeerVoice |
| Recipient: You |
| Company: Merck Serono |
| Recipient: You |
| Company: Samsung Bioepis |
| Recipient: You |
| Company: Bicycle Therapeutics |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Merck Sharp & Dohme |
| Recipient: Your Institution |
| Company: Gilead Sciences |
| Recipient: Your Institution |
| Company: Bristol-Myers Squibb/Celgene |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| Company: Merck Sharp & Dohme |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: Janssen |
| Recipient: You |
| Company: Gilead Sciences |
| Recipient: You |
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| not answered |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|